Testosterone and β-oestradiol prevent inward remodelling of rat small mesenteric arteries: Role of NO and transglutaminase

Clinical Science

Volumn 124, Issue 12, 2013, Pages 719-728

  Del Campo, Lara ^a,b,c   Tuna, Bilge Guven ^a   Ferrer, Mercedes ^b,c   Van Bavel, Ed ^a   Bakker, Erik N T P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

Nitric oxide; Sex hormone; Transglutaminase (TG); Vascular remodelling; Vascular structure

Indexed keywords

ENDOTHELIN 1; ESTRADIOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; FEMALE; LIGATION; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; ESTRADIOL; FEMALE; MALE; MESENTERIC ARTERIES; MYOGRAPHY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; TESTOSTERONE; TRANSGLUTAMINASES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84875520377     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120700     Document Type: Article

References (55)

1. Perusquia, M. and Stallone, J. N. (2010) Do androgens play a beneficial role in the regulation of vascular tone? nongenomic vascular effects of testosterone metabolites. Am. J. Physiol. Heart Circ. Physiol. 298, H1301-H1307
2. Duckles, S. P. and Miller, V. M. (2010) Hormonal modulation of endothelial NO production. Pflugers Arch. 459, 841-851
3. del Campo, L., Sagredo, A., Aras-Lopez, R., Balfagon, G. and Ferrer, M. (2008) Orchidectomy increases the formation of non-endothelial thromboxane A(2) and modulates its role in the
4. Blanco-Rivero, J., Sagredo, A., Balfagon, G. and Ferrer, M. (2007) Protein kinase C activation increases endothelial nitric oxiderelease in mesenteric arteries from orchidectomized rats. J. Endocrinol. 192, 189-197
5. Martorell, A., Sagredo, A., Aras-Lopez, R., Balfagon, G. and Ferrer, M. (2009) Ovariectomy increases the formation of prostanoids and modulates their role in acetylcholine-induced
6. Blanco-Rivero, J., Aras-Lopez, R., Del Campo, L., Sagredo, A., Balfagon, G. and Ferrer, M. (2006) Orchidectomy increases β-adrenoceptor activation-mediated neuronal nitric oxide and noradrenaline release in rat mesenteric artery. Neuroendocrinology 84, 378-385
7. Bonnet, S., Paulin, R., Sutendra, G., Dromparis, P., Roy, M., Watson, K. O., Nagendran, J., Haromy, A., Dyck, J. R. and Michelakis, E. D. (2009) Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-β/NFAT axis. Circulation 120, 1231-1240
8. Tofovic, P. S., Zhang, X. and Petrusevska, G. (2009) Progesterone inhibits vascular remodeling and attenuates monocrotalineinduced pulmonary hypertension in estrogen-deficient rats. Prilozi 30, 25-44
9. Ii, M., Hoshiga, M., Negoro, N., Fukui, R., Nakakoji, T., Kohbayashi, E., Shibata, N., Furutama, D., Ishihara, T., Hanafusa, T. et al. (2009) Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury. Atherosclerosis 206, 77-85
10. Mulvany, M. J. (2002) Small artery remodeling and significance in the development of hypertension. N. Physiol. Sci. 17, 105-109
11. van den Akker, J., Schoorl, M. J., Bakker, E. N. and Vanbavel, E. (2010) Small artery remodeling: current concepts and questions. J. Vasc. Res. 47, 183-202
12. Prewitt, R. L., Rice, D. C. and Dobrian, A. D. (2002) Adaptation of resistance arteries to increases in pressure. Microcirculation 9, 295-304
13. Bakker, E. N., Matlung, H. L., Bonta, P., de Vries, C. J., van Rooijen, N. and Vanbavel, E. (2008) Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc. Res. 78, 341-348
14. Bakker, E. N., van der Meulen, E. T., van den Berg, B. M., Everts, V., Spaan, J. A. and VanBavel, E. (2002) Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J. Vasc. Res. 39, 12-20
15. Bakker, E. N., Buus, C. L., VanBavel, E. and Mulvany, M. J. (2004) Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J. Vasc. Res. 41, 174-182
16. Heagerty, A. M., Aalkjaer, C., Bund, S. J., Korsgaard, N. and Mulvany, M. J. (1993) Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension 21, 391-397
17. Rizzoni, D., Porteri, E., Boari, G. E., De Ciuceis, C., Sleiman, I., Muiesan, M. L., Castellano, M., Miclini, M. and Agabiti-Rosei, E. (2003) Prognostic significance of small-artery structure in hypertension. Circulation 108, 2230-2235
18. Bakker, E. N., Buus, C. L., Spaan, J. A., Perree, J., Ganga, A., Rolf, T. M., Sorop, O., Bramsen, L. H., Mulvany, M. J. and Vanbavel, E. (2005) Small artery remodeling depends on tissue-type transglutaminase. Circ. Res. 96, 119-126
19. Pistea, A., Bakker, E. N., Spaan, J. A., Hardeman, M. R., van Rooijen, N. and VanBavel, E. (2008) Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases. J. Vasc. Res. 45, 10-18
20. Bakker, E. N., Pistea, A., Spaan, J. A., Rolf, T., de Vries, C. J., van Rooijen, N., Candi, E. and VanBavel, E. (2006) Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ. Res. 99, 86-92
21. Thomazy, V. and Fesus, L. (1989) Differential expression of tissue transglutaminase in human cells: an immunohistochemical study. Cell Tissue Res. 255, 215-224
22. Lorand, L. and Graham, R. M. (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4, 140-156
23. Bakker, E. N., Pistea, A. and VanBavel, E. (2008) Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J. Vasc. Res. 45, 271-278
24. Aeschlimann, D. and Thomazy, V. (2000) Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect. Tissue Res. 41, 1-27
25. Lai, T. S., Hausladen, A., Slaughter, T. F., Eu, J. P., Stamler, J. S. and Greenberg, C. S. (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40, 4904-4910
26. Smethurst, P. A. and Griffin, M. (1996) Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem. J. 313 (Pt 3), 803-808
27. Mulvany, M. J. and Halpern, W. (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41, 19-26
28. Ganguly, S., Ashley, L. A., Pendleton, C. M., Grey, R. D., Howard, G. C., Castle, L. D., Peyton, D. K., Fultz, M. E. and DeMoss, D. L. (2008) Characterization of osteoblastic properties of 7F2 and UMR-106 cultures after acclimation to reduced levels of fetal bovine serum. Can. J. Physiol. Pharmacol. 86, 403-415
29. Ferrer, M., Meyer, M. and Osol, G. (1996) Estrogen replacement increases β-adrenoceptor-mediated relaxation of rat mesenteric arteries. J. Vasc. Res. 33, 124-131
30. Martorell, A., Blanco-Rivero, J., Aras-Lopez, R., Sagredo, A., Balfagon, G. and Ferrer, M. (2008) Orchidectomy increases the formation of prostanoids and modulates their role in the acetylcholine-induced relaxation in the rat aorta. Cardiovasc. Res. 77, 590-599
31. Ullah, M. I., Washington, T., Kazi, M., Tamanna, S. and Koch, C. A. (2011) Testosterone deficiency as a risk factor for cardiovascular disease. Horm. Metab. Res. 43, 153-164
32. Yang, X. P. and Reckelhoff, J. F. (2011) Estrogen, hormonal replacement therapy and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 20, 133-138
33. English, K. M., Mandour, O., Steeds, R. P., Diver, M. J., Jones, T. H. and Channer, K. S. (2000) Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur. Heart J. 21, 890-894
34. Dubey, R. K. and Jackson, E. K. (2001) Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am. J. Physiol. Renal Physiol. 280, F365-F388
35. Mendelsohn, M. E. and Karas, R. H. (1999) The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340, 1801-1811
36. Corona, G., Rastrelli, G., Vignozzi, L., Mannucci, E. and Maggi, M. (2011) Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 25, 337-353
37. Haddad, R. M., Kennedy, C. C., Caples, S. M., Tracz, M. J., Bolona, E. R., Sideras, K., Uraga, M. V., Erwin, P. J. and Montori, V. M. (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin. Proc. 82, 29-39
38. Wu, F. C. and von Eckardstein, A. (2003) Androgens and coronary artery disease. Endocr. Rev. 24, 183-217
39. Barrett-Connor, E. and Bush, T. L. (1991) Estrogen and coronary heart disease in women. JAMA 265, 1861-1867
40. Ahimastos, A. A., Formosa, M., Dart, A. M. and Kingwell, B. A. (2003) Gender differences in large artery stiffness pre- and post puberty. J. Clin. Endocrinol. Metab. 88, 5375-5380
41. Waddell, T. K., Dart, A. M., Gatzka, C. D., Cameron, J. D. and Kingwell, B. A. (2001) Women exhibit a greater age-related increase in proximal aortic stiffness than men. J. Hypertens. 19, 2205-2212
42. Son, B. K., Akishita, M., Iijima, K., Ogawa, S., Maemura, K., Yu, J., Takeyama, K., Kato, S., Eto, M. and Ouchi, Y. (2010) Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. J. Biol. Chem. 285, 7537-7544
43. Morita, T., Okada, M., Hara, Y. and Yamawaki, H. (2011) Mechanisms underlying impairment of endothelium-dependent relaxation by fetal bovine serum in organ-cultured rat mesenteric artery. Eur. J. Pharmacol. 668, 401-406
44. Bakker, E. N., van Der Meulen, E. T., Spaan, J. A. and VanBavel, E. (2000) Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am. J. Physiol. Heart Circ. Physiol. 278, H1233-40
45. Eftekhari, A., Rahman, A., Schaebel, L. H., Chen, H., Rasmussen, C. V., Aalkjaer, C., Buus, C. L. and Mulvany, M. J. (2007) Chronic cystamine treatment inhibits small artery remodelling in rats. J. Vasc. Res. 44, 471-482
46. Langille, B. L. and Dajnowiec, D. (2005) Cross-linking vasomotor tone and vascular remodeling: a novel function for tissue transglutaminase? Circ. Res. 96, 9-11
47. van den Akker, J., VanBavel, E., van Geel, R., Matlung, H. L., Guvenc Tuna, B., Janssen, G. M., van Veelen, P. A., Boelens, W. C., De Mey, J. G. and Bakker, E. N. (2011) The redox state of transglutaminase 2 controls arterial remodeling. PLoS ONE 6, e23067
48. Chakrabarti, S., Lekontseva, O., Peters, A. and Davidge, S. T. (2010) 17β-estradiol induces protein S-nitrosylation in the endothelium. Cardiovasc. Res. 85, 796-805
49. Furukawa, T. and Kurokawa, J. (2008) Non-genomic regulation of cardiac ion channels by sex hormones. Cardiovasc. Hematol. Disord. Drug Targets 8, 245-251
50. Zhang, H. H., Feng, L., Livnat, I., Hoh, J. K., Shim, J. Y., Liao, W. X. and Chen, D. B. (2010) Estradiol-17β stimulates specific receptor and endogenous nitric oxide-dependent dynamic endothelial protein S-nitrosylation: analysis of endothelial nitrosyl-proteome. Endocrinology 151, 3874-3887
51. Bernassola, F., Rossi, A. and Melino, G. (1999) Regulation of transglutaminases by nitric oxide. Ann. N.Y. Acad. Sci. 887, 83-91
52. Simpson, E. R. (2003) Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 86, 225-230
53. Wenger, N. K., Speroff, L. and Packard, B. (1993) Cardiovascular health and disease in women. N. Engl. J. Med. 329, 247-256
54. del Campo, L., Ferrer, M. and Balfagon, G. (2009) Hypertension alters the function of nitrergic and sensory innervation in mesenteric arteries from female rats. J. Hypertens. 27, 791-799
55. Mulvany, M. J. (2005) Abnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy. Pharmacol. Rep. 57 (Suppl.), 144-150 Received 21 December 2012; accepted 21 January 2013 Published as Immediate Publication 21 January 2013, doi: 10.1042/CS20120700 728 C